Self-Administered Lidocaine Gel for Intrauterine Device Insertion in Nulliparous Women: A Randomized Controlled Trial

Obstetrics and Gynecology

Volumn 128, Issue 3, 2016, Pages 621-628

  Rapkin, Rachel B ^a   Achilles, Sharon L ^a   Schwarz, E Bimla ^a   Meyn, Leslie ^a   Cremer, Miriam ^a   Boraas, Christy M ^a   Chen, Beatrice A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIDOCAINE; AGENTS USED INTRAVAGINALLY; LOCAL ANESTHETIC AGENT;

AGE; BODY MASS; CONFERENCE PAPER; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG SELF ADMINISTRATION; FEMALE; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; NULLIPARA; OUTCOME ASSESSMENT; PAIN; PRIORITY JOURNAL; RACE; RANDOMIZED CONTROLLED TRIAL; TENACULUM; UTERINE SOUND; VISUAL ANALOG SCALE; ADULT; ADVERSE EFFECTS; PAIN MEASUREMENT; PARITY; SURGICAL EQUIPMENT; YOUNG ADULT;

ADULT; ANESTHETICS, LOCAL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INTRAUTERINE DEVICES; LIDOCAINE; PAIN; PAIN MEASUREMENT; PARITY; SELF ADMINISTRATION; SURGICAL INSTRUMENTS; VAGINAL CREAMS, FOAMS, AND JELLIES; YOUNG ADULT;

EID: 84981294592     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000001596     Document Type: Conference Paper

References (17)

1. Increasing access to contraceptive implants and intrauterine devices to reduce unintended pregnancy. Committee Opinion No. 642. American College of Obstetricians and Gynecologists. Obstet Gynecol 2015;126:e44-8.
2. Committee on Adolescence. Contraception for adolescents. Pediatrics 2014;134:e1244-56.
3. Kavanaugh ML, Jerman J, Finer LB. Changes in use of longacting reversible contraceptive methods among U.S. Women, 2009-2012. Obstet Gynecol 2015;126:917-27.
4. Bracken J, Graham CA. Young women's attitudes towards, and experiences of, long-acting reversible contraceptives. Eur J Contracept Reprod Health Care 2014;19:276-84.
5. Michie L, Cameron ST, Glasier A, Wellings K, Loudon J. Myths and misconceptions about intrauterine contraception among women seeking termination of pregnancy. J Fam Plan Reprod Health Care 2014;40:36-40.
6. Potter J, Rubin SE, Sherman P. Fear of intrauterine contraception among adolescents in New York City. Contraception 2014; 89:446-50.
7. Asker C, Stokes-Lampard H, Beavan J, Wilson S. What is it about intrauterine devices that women find unacceptable? Factors that make women non-users: a qualitative study. J Fam Plann Reprod Health Care 2006;32:89-94.
8. Fleming KL, Sokoloff A, Raine TR. Attitudes and beliefs about the intrauterine device among teenagers and young women. Contraception 2010;82:178-82.
9. Hubacher D, Reyes V, Lillo S, Zepeda A, Chen PL, Croxatto H. Pain from copper intrauterine device insertion: randomized trial of prophylactic ibuprofen. Am J Obstet Gynecol 2006;195:1272-7.
10. Suhonen S, Haukkamaa M, Jakobsson T, Rauramo I. Clinical performance of a levonorgestrel-releasing intrauterine system and oral contraceptives in young nulliparous women: a comparative study. Contraception 2004;69:407-12.
11. Lopez LM, Bernholc A, Zeng Y, Allen RH, Bartz D, O'Brien PA, et al. Interventions for pain with intrauterine device insertion. The Cochrane Database of Systematic Review 2015, Issue 7. Art. No.: CD007373. DOI: 10.1002/14651858. CD007373.pub3.
12. McNicholas CP, Madden T, Zhao Q, Secura G, Allsworth JE, Peipert JF. Cervical lidocaine for IUD insertional pain: a randomized controlled trial. Am J Obstet Gynecol 2012;207:384. e1-6.
13. Maguire K, Davis A, Rosario Tejeda L, Westhoff C. Intracervical lidocaine gel for intrauterine device insertion: a randomized controlled trial. Contraception 2012;86:214-9.
14. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42:377-81.
15. Edelman AB, Schaefer E, Olson A, Van Houten L, Bednarek P, Leclair C, et al. Effects of prophylactic misoprostol administration prior to intrauterine device insertion in nulliparous women. Contraception 2011;84:234-9.
16. Gemzell-Danielsson K, Buhling KJ, Dermout SM, Lukkari-Lax E, Montegriffo E, Apter D. A phase III, single-arm study of LNG-IUS 8, a low-dose levonorgestrel intrauterine contraceptive system (total content 13.5mg) in postmenarcheal adolescents. Contraception 2016;93:507-12.
17. Tavakolian S, Doulabi MA, Baghban AA, Mortazavi A, Ghorbani M. Lidocaine-prilocaine cream as analgesia for IUD insertion: a prospective, randomized, controlled, triple blinded study. Glob J Health Sci 2015;7:399-404.